Close Menu
financedailytip.com
    What's Hot

    9/11’s Long Shadow

    September 10, 2026

    Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit – Slideshow (NASDAQ:CRDF) 2026-09-10

    September 10, 2026

    Are interest rates on their way up again?

    September 10, 2026
    Facebook X (Twitter) Instagram
    Trending
    • 9/11’s Long Shadow
    • Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit – Slideshow (NASDAQ:CRDF) 2026-09-10
    • Are interest rates on their way up again?
    • Roper Technologies In Rebound and a Hot Buy Despite Insider Selling
    • CrowdStrike Holdings, Inc. (CRWD) Presents at Goldman Sachs Communacopia + Technology Conference 2026 Transcript
    • Alstom to build new battery-electric train fleet
    • Apple Just Raised iPhone Pro Starting Prices by $100. Its Memory Costs Are Rising Even Faster.
    • Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage
    Facebook X (Twitter) Instagram
    financedailytip.com
    • Home
    • Business
      • Company News
      • Corporate Earnings
      • Entrepreneurship
      • Mergers & Acquisitions
      • Startups
    • Cryptocurrency
      • Altcoins
      • Bitcoin
      • Blockchain
      • DeFi
      • Ethereum
    • Economy
      • Global Economy
      • Government Policies
      • Inflation
      • Interest Rates
      • Recession
    • Finance
      • Banking
      • Economy
      • FinTech
      • Investing
      • Personal Finance
    • Forex
      • Economic Calendar
      • Forex News
      • Fundamental Analysis
      • Technical Analysis
      • Trading Signals
    • Investing
      • Dividend Investing
      • ETF Investing
      • Growth Investing
      • Portfolio Management
      • Value Investing
    • Stock Market
      • Asian Stocks
      • Earnings Reports
      • European Stocks
      • IPOs
      • US Stocks
    Thursday, September 10
    financedailytip.com
    Home»Investing»Growth Investing»Oracle Stock Just Hit a 52-Week Low: 20 Billion Reasons NOT to Buy the Dip
    Growth Investing

    Oracle Stock Just Hit a 52-Week Low: 20 Billion Reasons NOT to Buy the Dip

    AdminBy AdminJuly 29, 2026Updated:July 31, 2026No Comments3 Mins Read
    Facebook Twitter LinkedIn Telegram Pinterest Tumblr Reddit WhatsApp Email Copy Link
    Oracle Stock Just Hit a 52-Week Low: 20 Billion Reasons NOT to Buy the Dip
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Oracle (ORCL -0.89%) stock has navigated a volatile path throughout 2026. Shares began the year around $196, eventually climbing to a high of $248 amid optimism around artificial intelligence (AI) cloud contracts.

    However, over the last couple of months, Oracle stock has cratered — plummeting more than 50% and collapsing to a 52-week low. This recent trough may invite speculation that the dip is buyable, but the combination of extraordinary spending needs and uncertainties around external financing environments suggests otherwise.

    Oracle logo.

    Image source: The Motley Fool.

    Oracle is generating record growth, but…

    Oracle’s fiscal fourth-quarter 2026 results showcased remarkable expansion in its AI business. Total revenue during the quarter reached $19.2 billion, up 21% year over year. Sales from cloud infrastructure surged to $5.8 billion, a 93% increase year over year. For the full fiscal year, revenue climbed 17% to $67.4 billion while total cloud (infrastructure services and application software) advanced 39% to $34.0 billion.

    Remaining performance obligations were the real standout, soaring to $638 billion — up 363% year over year. These deals continue to be fueled by massive multi-year AI training and inference deals with AI developers.

    While these figures are staggering by any measure, Oracle has continued to fall. The reason is simple: Investors are less focused on the company’s backlog and more concerned about the capital intensity required to deliver it.

    …the costs of infrastructure are mounting, and…

    Oracle’s capital expenditures (capex) tell the real story behind the company’s AI-driven growth. Fiscal 2026 capex ballooned to $55.7 billion, more than doubling the prior year’s $21.2 billion outlay. The surge is driven almost exclusively by the accelerating build-outs of AI data centers and the acquisition of high-performance computing clusters needed to support the cloud backlog.

    ORCL Capital Expenditures (TTM) Chart

    ORCL Capital Expenditures (TTM) data by YCharts

    These investments produced a severe cash-flow deficit. Free cash flow for fiscal 2026 turned negative at $23.7 billion, even as operating cash flow itself rose 54% to $32.0 billion. The disparity between robust operating cash and negative free cash flow leaves Oracle heavily dependent on external capital markets to keep its infrastructure program on track.

    …Fed Chair Kevin Warsh may throw cold water on the AI revolution

    In principle, Oracle must spend aggressively to convert its backlog into realized revenue. The scale and method of funding, however, introduce meaningful risk for shareholders.

    During fiscal 2026, Oracle issued $43 billion of debt. Looking ahead, management has signaled plans to raise roughly $40 billion more in fiscal 2027, including a $20 billion at-the-market (ATM) equity program authorized back in February. This ATM facility creates a mechanism for dilution whenever the share price recovers.

    Another layer of uncertainty comes from interest rate dynamics. While some economists still anticipate possible rate cuts later this year, new Federal Reserve Chair Kevin Warsh may have other plans. Rate hikes are very much on the table, and any sustained period of rising interest rates would increase the cost of Oracle’s already substantial debt load.

    This could potentially force a slowdown in the company’s data center expansion. In turn, a deceleration in capital spending would delay the conversion of Oracle’s infrastructure backlog into growth, undermining the very narrative supporting the bull thesis.

    For this reason, Oracle’s plummeting share price reflects more than temporary pessimism — it prices in the elevated risk that the path to converting record backlog into sustainable profitability remains expensive, dilutive, and contingent on favorable financing conditions.

    52Week Billion Buy Dip hit Oracle Reasons Stock
    Share. Facebook Twitter Pinterest Tumblr LinkedIn Telegram Email
    Previous ArticleUnited Airlines Insider Sheds 13,794 Shares for $1.6 Million, According to Latest SEC Filing
    Next Article The Lesser-Known Way to Tap Your 401(k) Before 59 1/2 Penalty-Free
    Admin
    • Website

    Related Posts

    Roper Technologies In Rebound and a Hot Buy Despite Insider Selling

    September 10, 2026

    Buy now or wait and hope? Families face gamble on heating oil

    September 10, 2026

    Better eVTOL Stock: Archer Aviation vs. Joby Aviation

    September 10, 2026
    Add A Comment
    Leave A Reply Cancel Reply

    Top Posts

    Subscribe to Updates

    Get the latest sports news from SportsSite about soccer, football and tennis.

    About us

    Welcome to **FinanceDailyTip.com**, your trusted destination for the latest financial news, market insights, and practical money tips.

    Our mission is to help readers stay informed about the ever-changing world of finance by delivering timely, accurate, and easy-to-understand content. Whether you're an investor, trader, entrepreneur, or simply looking to improve your financial knowledge, FinanceDailyTip.com is here to keep you updated.

    OUR PICKS

    9/11’s Long Shadow

    September 10, 2026

    Cardiff Oncology, Inc. (CRDF) Presents at 8th Annual RAS-Targeted Drug Development Summit – Slideshow (NASDAQ:CRDF) 2026-09-10

    September 10, 2026

    Are interest rates on their way up again?

    September 10, 2026
    Get Informed

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    © 2026 FinanceDailyTip.com. All Rights Reserved.
    • Privacy Policy
    • Terms and Conditions
    • Contact Us
    • About Us

    Type above and press Enter to search. Press Esc to cancel.